If you experience any of these signs, you should get immediate medical attention
Given the copper pathways implicated, users with pre-existing copper overload, Wilson disease, or severe liver disease may be at increased risk and should avoid use
Some people may start to see results within a few weeks, while for others it may take a few months
The duration problem might be mitigated via coadministration with a PDE5 inhibitor, which yielded good results in a small 2005 study.8 Yet research on this approach remains limited
She continues, "The cardiovascular protection and other emerging benefits, such as improvements in outcomes related to metabolic-associated liver disease and obstructive sleep apnea, are additional benefits of these medications." About the Author Jennifer Fisher, MMSc, PA-C, Health Writer About the Reviewer Chika V
The latter enrolled 190 patients with obesity (mean age 54.4 years, mean BMI 36.1 kg/m 2 ) and biopsy-proven MASH and moderate-to-severe fibrosis regardless of the presence of T2D, showing a BW reduction of 10.7%, 13.3%, 15.6% and 0.8% at 52 weeks with tirzepatide 5 mg, 10 mg, 15 mg and placebo, respectively 39
